Cargando…

Study of expression of endoglin (CD105) in oral squamous cell carcinoma

CONTEXT: Oral cancer is the 8(th) most common cancer in the world. An important feature of carcinogenesis is angiogenesis. Endoglin is a powerful marker of neovascularization in solid malignancies. This study was done to ascertain its role as an indicator of metastasis and prognosis. AIM: This study...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mahapatra, Niva, Uma Rao, Krishna Devi, Ranganathan, Kannan, Joshua, Elizabeth, Thavarajah, Rooban
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Medknow Publications & Media Pvt Ltd 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8859600/ https://www.ncbi.nlm.nih.gov/pubmed/35281173 http://dx.doi.org/10.4103/jomfp.jomfp_13_21

Ejemplares similares

Loss of heterozygosity as a marker to predict progression of oral epithelial dysplasia to oral squamous cell carcinoma
por: Rao, Umadevi Krishna Mohan, et al.
Publicado: (2018)

Trends in oral squamous cell carcinoma: Diagnosis for effective, evidence-based treatment 2017
por: Thavarajah, Rooban, et al.
Publicado: (2017)

Expression of endoglin (CD105) in cervical cancer
por: Zijlmans, H J, et al.
Publicado: (2009)

NLP and oral health information
por: Selvan, Preetha, et al.
Publicado: (2023)

Evaluation of Endoglin (CD105) expression in pediatric rhabdomyosarcoma
por: Di Paolo, Virginia, et al.
Publicado: (2018)

Survey of responsible handling of local anesthetic in Indian dental operatory
por: Rooban, Thavarajah, et al.
Publicado: (2013)

E-cadherin Expression in Premalignant Lesions, Premalignant Conditions, Oral Squamous Cell Carcinoma, and Normal Mucosa: An Immunohistochemical Study
por: Kalaimani, Gnanambigai, et al.
Publicado: (2023)

Horoscopic role of CD105 (Endoglin) in progression of oral lichen planus: An immunohistochemical study
por: Parvathala, Poornima, et al.
Publicado: (2021)

CD105 (Endoglin) as negative prognostic factor in AML
por: Kauer, Joseph, et al.
Publicado: (2019)

Decoding the link associated with areca nut chewing and cardiovascular disease using hsCRP as a biomarker
por: Vasanthi, V, et al.
Publicado: (2022)

Potential role of septins in oral carcinogenesis: An update and avenues for future research
por: Thavarajah, Rooban, et al.
Publicado: (2012)

Particular distribution and expression pattern of endoglin (CD105) in the liver of patients with hepatocellular carcinoma
por: Yu, Decai, et al.
Publicado: (2007)

Endoglin (CD105) expression in ovarian serous carcinoma effusions is related to chemotherapy status
por: Bock, Annika J., et al.
Publicado: (2011)

Role of Endoglin (CD105) in the Progression of Hepatocellular Carcinoma and Anti-Angiogenic Therapy
por: Kasprzak, Aldona, et al.
Publicado: (2018)

Chemical and physical basics of routine formaldehyde fixation
por: Thavarajah, Rooban, et al.
Publicado: (2012)

Identification of CD105 (endoglin) as novel risk marker in CLL
por: Greiner, Sarah M., et al.
Publicado: (2022)

Expression of p53 and Cyclin D1 in oral squamous cell carcinoma and normal mucosa: An Immunohistochemical study
por: Swaminathan, Uma, et al.
Publicado: (2012)

A Study on Drug-Induced Tardive Dyskinesia: Orofacial Musculature Involvement and Patient’s Awareness
por: Anusa, Arunachalam M., et al.
Publicado: (2019)

PROGNOSTIC ROLE OF CD44 EXPRESSION AND NEOVASCULARIZATION DETERMINED BY ENDOGLIN (CD105) IN GLIOBLASTOMA PATIENTS
por: Mihić, Josip, et al.
Publicado: (2019)

ENDOGLIN/CD105 is expressed in KIT positive cells in the gut and in gastrointestinal stromal tumours
por: Gromova, Petra, et al.
Publicado: (2012)

Endoglin (CD105) and VEGF as potential angiogenic and dissemination markers for colorectal cancer
por: Nogués, Ana, et al.
Publicado: (2020)

Endoglin and squamous cell carcinomas
por: Hakuno, Sarah K., et al.
Publicado: (2023)

Continuous endoglin (CD105) overexpression disrupts angiogenesis and facilitates tumor cell metastasis
por: Ollauri-Ibáñez, Claudia, et al.
Publicado: (2020)

Hot and Cold Tumors: Is Endoglin (CD105) a Potential Target for Vessel Normalization?
por: Ollauri-Ibáñez, Claudia, et al.
Publicado: (2021)

Endoglin/CD105-Based Imaging of Cancer and Cardiovascular Diseases: A Systematic Review
por: Sier, Vincent Q., et al.
Publicado: (2021)

Endoglin (CD105) and proliferation index in recurrent glioblastoma treated with anti-angiogenic therapy
por: Bastos, António G. P., et al.
Publicado: (2022)

Tooth decay in alcohol and tobacco abusers
por: Rooban, Thavarajah, et al.
Publicado: (2011)

Influence of legislations and news on Indian internet search query patterns of e-cigarettes
por: Thavarajah, Rooban, et al.
Publicado: (2017)

Impact of highly active antiretroviral therapy on salivary flow in patients with human-immuno deficiency virus disease in Southern India
por: Pavithra, S, et al.
Publicado: (2013)

Highlights on endoglin (CD105): from basic findings towards clinical applications in human cancer
por: Fonsatti, Ester, et al.
Publicado: (2004)

Endoglin (CD105) as a putative prognostic biomarker for colorectal cancer: a systematic review
por: Sur, Daniel, et al.
Publicado: (2022)

Review of paraneoplastic syndromes associated with oropharyngeal squamous cell carcinoma
por: Mathew, Deepu George, et al.
Publicado: (2010)

Microglial Phenotyping in Neurodegenerative Disease Brains: Identification of Reactive Microglia with an Antibody to Variant of CD105/Endoglin
por: Walker, Douglas G., et al.
Publicado: (2019)

Endoglin (CD105) is a more appropriate marker than CD31 for detecting microvessels in carotid artery plaques
por: Fukumitsu, Ryu, et al.
Publicado: (2013)

Endoglin (CD105) expression differentiates between aseptic loosening and periprosthetic joint infection after total joint arthroplasty
por: Jansen, Philipp, et al.
Publicado: (2014)

Expression of CD44 in Head and Neck Squamous Cell Carcinoma—An In-Silico Study
por: Kavitha, Loganathan, et al.
Publicado: (2023)

Immunohistochemical study of CD44s expression in oral squamous cell carcinoma-its correlation with prognostic parameters
por: Hema, KN, et al.
Publicado: (2014)

Cancer Stem Cell Marker Endoglin (CD105) Induces Epithelial Mesenchymal Transition (EMT) but Not Metastasis in Clear Cell Renal Cell Carcinoma
por: Hu, Junhui, et al.
Publicado: (2019)

CD105 (Endoglin) exerts prognostic effects via its role in the microvascular niche of paediatric high grade glioma
por: Smith, Stuart J., et al.
Publicado: (2012)

A bioinformatic analysis of the inhibin-betaglycan-endoglin/CD105 network reveals prognostic value in multiple solid tumors
por: Listik, Eduardo, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_l9k6mt3k14356p14t0sd37ssi3